Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., . . . Höflmayer, D. (2019). Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget.
Citação norma ChicagoSchroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
Citação norma MLASchroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.